Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

224.36
Delayed Data
As of 4:02pm ET
 +0.20 / +0.09%
Today’s Change
184.50
Today|||52-Week Range
261.27
+6.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Operating ActivitiesNet Income / Starting Line-499.9M15.2B1.2M-2.6B
 
 
 
 
 
Depreciation1.7B1.6B1.7B1.8B
 
 
 
 
 
Total Other Cash Flow429.3M-18.2B-415.1M2.5B
 
 
 
 
 
Funds From Operations1.8B-1.6B342.9M959.1M
 
 
 
 
 
Funds From/For Other Operating Expenses402.4M-459.8M426.2M235.8M
 
 
 
 
 
Net Cash Flow - Operating Activities1.4B-1.1B-83.3M723.3M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-15.4B-298.0M-6.4B
 
 
 
 
Decrease In Investments6.5M------
 
 
Capital Expenditures-97.9M-67.7M-80.9M-33.2M
 
 
 
 
 
Fixed Asset Disposal2.4M33.3B499.7M700.0K
 
 
 
 
 
Net Assets From Acquisitions 0.00-74.5M-1.1B-2.9B
 
 
 
 
Other Investing - Sources0.0040.0M7.7B9.7B
 
 
 
 
Net Cash Flow Investing-89.0M17.8B6.7B14.2M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.00150.0M0.000.00
 
 
Long Term Debt Reduction-3.0B-7.0B-17.7M-1.0B
 
 
 
 
 
Net Proceeds Stock Sale37.7M30.7M34.1M52.6M
 
 
 
 
 
Common Preferred Redeemed-14.1M-2.7B-12.3B-29.5M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-69.6M-69.6M-69.6M-305.8M
 
 
 
 
 
Other Sources - Financing-2.7M-5.3M-6.2M--
 
 
 
 
Other Uses - Financing31.5M13.9M83.4M76.3M
 
 
 
 
 
Net Cash Flow - Financing-3.1B-9.6B-12.5B-1.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-3.2M2.3M-12.8M6.3M
 
 
 
 
 
 
Net Change In Cash-1.8B7.1B-5.8B-637.4M